Gritstone bio, Inc.

NASDAQ:GRTS

0.0322 (USD) • At close October 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019201820172016
Revenue 1.3319.26946.7174.0374.3651.18700
Cost of Revenue 7.59115.69114.39988.64382.89654.9651.970.823
Gross Profit -6.26-6.42232.318-84.606-78.531-53.778-1.97-0.823
Gross Profit Ratio -4.703-0.6930.692-20.958-17.991-45.30600
Reseach & Development Expenses 127.182111.40397.4988.64382.89654.96535.69113.916
General & Administrative Expenses 28.78328.9725.93321.41119.40911.8066.0725.064
Selling & Marketing Expenses -7.5910000000
SG&A 21.19228.9725.93321.41119.40911.8066.0725.064
Other Expenses -0.032-10.676-1.49700000
Operating Expenses 148.374129.697121.926110.054102.30566.77141.76318.98
Operating Income -154.634-120.428-75.209-106.017-97.94-65.584-41.763-18.98
Operating Income Ratio -116.179-12.993-1.61-26.261-22.438-55.25200
Total Other Income Expenses Net 16.1440.7410.1270.7033.5070.8090.3860.23
Income Before Tax -138.49-119.687-75.082-105.314-94.433-64.775-41.377-18.75
Income Before Tax Ratio -104.05-12.913-1.607-26.087-21.634-54.5700
Income Tax Expense 7.423-6.56-0.127-0.703-3.5070.80900
Net Income -138.49-113.127-74.955-104.611-90.926-64.775-41.377-18.75
Net Income Ratio -104.05-12.205-1.604-25.913-20.831-54.5700
EPS -1.2-1.24-0.95-2.77-2.71-7.26-2.06-0.93
EPS Diluted -1.2-1.24-0.95-2.77-2.71-7.26-2.06-0.93
EBITDA -147.043-118.452-68.862-99.373-93.195-61.623-39.793-18.157
EBITDA Ratio -110.476-12.779-1.474-24.616-21.351-51.91500